BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second ...

Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the ...

The move comes after Robert F. Kennedy Jr. received pressure from the Children’s Health Defense, an anti-vaccine non-profit ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a ...

The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new ...

WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An ...

The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S.

After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be ...

In May 2025, the White House announced a ‘Most Favored Nation’ approach for setting prescription drug prices. The order aims ...

The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” ...

Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy ...